Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial.

Perrone F, Piccirillo MC, Ascierto PA, Salvarani C, Parrella R, Marata AM, Popoli P, Ferraris L, Marrocco-Trischitta MM, Ripamonti D, Binda F, Bonfanti P, Squillace N, Castelli F, Muiesan ML, Lichtner M, Calzetti C, Salerno ND, Atripaldi L, Cascella M, Costantini M, Dolci G, Facciolongo NC, Fraganza F, Massari M, Montesarchio V, Mussini C, Negri EA, Botti G, Cardone C, Gargiulo P, Gravina A, Schettino C, Arenare L, Chiodini P, Gallo C, TOCIVID-19 investigators, Italy

Open source

DOI: 10.1186/s12967-020-02573-9
Published: 2020 Oct 21
Container: Journal of translational medicine
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s12967-020-02573-9,
  title = {Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial.},
  author = {Perrone F and Piccirillo MC and Ascierto PA and Salvarani C and Parrella R and Marata AM and Popoli P and Ferraris L and Marrocco-Trischitta MM and Ripamonti D and Binda F and Bonfanti P and Squillace N and Castelli F and Muiesan ML and Lichtner M and Calzetti C and Salerno ND and Atripaldi L and Cascella M and Costantini M and Dolci G and Facciolongo NC and Fraganza F and Massari M and Montesarchio V and Mussini C and Negri EA and Botti G and Cardone C and Gargiulo P and Gravina A and Schettino C and Arenare L and Chiodini P and Gallo C and TOCIVID-19 investigators, Italy},
  year = {2020},
  journal = {Journal of translational medicine},
  doi = {10.1186/s12967-020-02573-9},
  url = {https://doi.org/10.1186/s12967-020-02573-9}
}

RIS

TY  - JOUR
TI  - Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial.
AU  - Perrone F
AU  - Piccirillo MC
AU  - Ascierto PA
AU  - Salvarani C
AU  - Parrella R
AU  - Marata AM
AU  - Popoli P
AU  - Ferraris L
AU  - Marrocco-Trischitta MM
AU  - Ripamonti D
AU  - Binda F
AU  - Bonfanti P
AU  - Squillace N
AU  - Castelli F
AU  - Muiesan ML
AU  - Lichtner M
AU  - Calzetti C
AU  - Salerno ND
AU  - Atripaldi L
AU  - Cascella M
AU  - Costantini M
AU  - Dolci G
AU  - Facciolongo NC
AU  - Fraganza F
AU  - Massari M
AU  - Montesarchio V
AU  - Mussini C
AU  - Negri EA
AU  - Botti G
AU  - Cardone C
AU  - Gargiulo P
AU  - Gravina A
AU  - Schettino C
AU  - Arenare L
AU  - Chiodini P
AU  - Gallo C
AU  - TOCIVID-19 investigators, Italy
PY  - 2020
JO  - Journal of translational medicine
DO  - 10.1186/s12967-020-02573-9
UR  - https://doi.org/10.1186/s12967-020-02573-9
ER  -

APA

F, P., MC, P., PA, A., C, S., R, P., AM, M., P, P., L, F., MM, M., D, R., F, B., P, B., N, S., F, C., ML, M., M, L., C, C., ND, S., L, A., M, C., M, C., G, D., NC, F., F, F., M, M., V, M., C, M., EA, N., G, B., C, C., P, G., A, G., C, S., L, A., P, C., C, G., & Italy, T. I. (2020). Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial.. Journal of translational medicine. https://doi.org/10.1186/s12967-020-02573-9

Source records

pubmed · retrieved 2026-09-26T03:02:30.813Z